Venture Certified
| 기술평가대출기업(중진공) | 2017-09-08 ~ 2019-09-07 | 20170401840 | 2017-09-08 |
| 기술평가대출기업(중진공) | 2019-10-22 ~ 2021-10-21 | 20190402282 | 2017-09-08 |
| 혁신성장유형 | 2021-10-22 ~ 2024-10-21 | 20211208030006 | 2017-09-08 |
| 혁신성장유형 | 2024-10-22 ~ 2027-10-21 | 20241119030031 | 2017-09-08 |
Revenue CAGR +20.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 224B | 172B | 154B |
| Operating Profit | 39B | 32B | 18B |
| Net Profit | 36B | 28B | 13B |
| Total Assets | 114B | 100B | 93B |
| Total Liabilities | 64B | 60B | 65B |
| Total Equity | 50B | 40B | 27B |
▲ 37.8%
▲ 56.3%
▲ 14.8%
▼ 33.7%
▲ 21.0%
| Name | Position | Role |
|---|---|---|
| 박은영 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 노니열매 부산물의 발효추출물을 포함하는 치주질환 예방 및 치료용 조성물 및 그 제조방법 | (주)엔에스티바이오 | 1020240070689 | 2024-05-30 | 공개 |
| 노니열매 부산물의 발효추출물을 포함하는 치주질환 예방 및 치료용 조성물 및 그 제조방법 | (주)엔에스티바이오 | 1020240070688 | 2024-05-30 | 등록 |
| 골관절염 개선 효과를 가진 발효 노니 농축액을 포함하는 조성물 | (주)엔에스티바이오 | 1020240063567 | 2024-05-16 | 공개 |
| 바나바 추출물을 포함하는 골다공증 예방, 개선 또는 치료용 조성물 | (주)엔에스티바이오 | 1020240004888 | 2024-01-11 | 공개 |
| 12-디옥시위타스트라모놀라이드와 그 유도체를 포함하는 근력 개선용 치료제 | (주)엔에스티바이오 | 1020230158922 | 2023-11-16 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 김포시",
"ceo_name": "박은영",
"certificate": [
{
"cert_number": "20170401840",
"changes": "",
"disclosure_date": "2017-09-08",
"first_cert_date": "2017-09-08",
"no": "1",
"type": "기술평가대출기업(중진공)",
"valid_period": "2017-09-08 ~ 2019-09-07"
},
{
"cert_number": "20190402282",
"changes": "",
"disclosure_date": "2019-10-22",
"first_cert_date": "2017-09-08",
"no": "2",
"type": "기술평가대출기업(중진공)",
"valid_period": "2019-10-22 ~ 2021-10-21"
},
{
"cert_number": "20211208030006",
"changes": "",
"disclosure_date": "2021-12-08",
"first_cert_date": "2017-09-08",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2021-10-22 ~ 2024-10-21"
},
{
"cert_number": "20241119030031",
"changes": "",
"disclosure_date": "2024-11-19",
"first_cert_date": "2017-09-08",
"no": "4",
"type": "혁신성장유형",
"valid_period": "2024-10-22 ~ 2027-10-21"
}
],
"company_name": "㈜ 엔에스티바이오",
"corp_no": "120111-*******",
"financials": {
"2022": {
"capital_stock": 998000000,
"cost_of_sales": 10403592000,
"current_assets": 5802711000,
"current_liabilities": 1671735000,
"gross_profit": 4984258000,
"net_income": 1300509000,
"net_income_bs": 1282706000,
"non_current_assets": 3459981000,
"non_current_liabilities": 4842531000,
"non_operating_expenses": 573758000,
"non_operating_income": 95701000,
"operating_profit": 1778566000,
"revenue": 15387850000,
"sga_expenses": 3205692000,
"total_assets": 9262692000,
"total_equity": 2748426000,
"total_liabilities": 6514266000
},
"2023": {
"capital_stock": 998000000,
"cost_of_sales": 10768858000,
"current_assets": 5301301000,
"current_liabilities": 1776486000,
"gross_profit": 6415927000,
"net_income": 2811825000,
"net_income_bs": 2733238000,
"non_current_assets": 4689733000,
"non_current_liabilities": 4262884000,
"non_operating_expenses": 421054000,
"non_operating_income": 34376000,
"operating_profit": 3198503000,
"revenue": 17184785000,
"sga_expenses": 3217424000,
"total_assets": 9991034000,
"total_equity": 3951664000,
"total_liabilities": 6039370000
},
"2024": {
"capital_stock": 997999000,
"cost_of_sales": 14704147000,
"current_assets": 4915153000,
"current_liabilities": 2049001000,
"gross_profit": 7743618000,
"net_income": 3569405000,
"net_income_bs": 3426858000,
"non_current_assets": 6498327000,
"non_current_liabilities": 4385957000,
"non_operating_expenses": 348464000,
"non_operating_income": 28731000,
"operating_profit": 3889138000,
"revenue": 22447765000,
"sga_expenses": 3854480000,
"total_assets": 11413480000,
"total_equity": 4978522000,
"total_liabilities": 6434958000
}
},
"industry": "그 외 기타 식료품 제조업",
"investment": [],
"main_products": "발효잡곡, 발효건노니,발효노니차,발효음료",
"phone": "031-996-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |